Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma

Clinical trial NCT03889912 · COMPLETED

Trial details

NCT number: NCT03889912
Sponsor: Regeneron Pharmaceuticals
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cutaneous Squamous Cell Carcinoma Basal Cell Carcinoma

Start date: 2019-04-11
Primary completion: 2025-11-13
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.